Artykuły w czasopismach na temat „Oral submucous fibrosis (OSF); precancerous disorder”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Oral submucous fibrosis (OSF); precancerous disorder”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Shih, Yin-Hwa, Tong-Hong Wang, Tzong-Ming Shieh, and Yu-Hsin Tseng. "Oral Submucous Fibrosis: A Review on Etiopathogenesis, Diagnosis, and Therapy." International Journal of Molecular Sciences 20, no. 12 (2019): 2940. http://dx.doi.org/10.3390/ijms20122940.
Pełny tekst źródłaSoham, Kulkarni Sachin Jadhav Sahil Shaikh* Suraj Gholap. "A Review on Screening Model for Submucosa Fibrosis." International Journal of Pharmaceutical Sciences 3, no. 5 (2025): 3445–56. https://doi.org/10.5281/zenodo.15475252.
Pełny tekst źródłaYou, Jie-Ru, Ya-Ting Chen, Chia-Yu Hsieh, et al. "Exploring Possible Diagnostic Precancerous Biomarkers for Oral Submucous Fibrosis: A Narrative Review." Cancers 15, no. 19 (2023): 4812. http://dx.doi.org/10.3390/cancers15194812.
Pełny tekst źródłaYu, Chuan-Hang, Chih-Yuan Fang, Cheng-Chia Yu, et al. "LINC00312/YBX1 Axis Regulates Myofibroblast Activities in Oral Submucous Fibrosis." International Journal of Molecular Sciences 21, no. 8 (2020): 2979. http://dx.doi.org/10.3390/ijms21082979.
Pełny tekst źródłaYu, Cheng-Chia, Yi-Wen Liao, Pei-Ling Hsieh, and Yu-Chao Chang. "Targeting lncRNA H19/miR-29b/COL1A1 Axis Impedes Myofibroblast Activities of Precancerous Oral Submucous Fibrosis." International Journal of Molecular Sciences 22, no. 4 (2021): 2216. http://dx.doi.org/10.3390/ijms22042216.
Pełny tekst źródłaPeng, Chih-Yu, Yi-Wen Liao, Ming-Yi Lu, Chieh-Mei Yang, Pei-Ling Hsieh, and Cheng-Chia Yu. "Positive Feedback Loop of SNAIL-IL-6 Mediates Myofibroblastic Differentiation Activity in Precancerous Oral Submucous Fibrosis." Cancers 12, no. 6 (2020): 1611. http://dx.doi.org/10.3390/cancers12061611.
Pełny tekst źródłaParikh, Pratyush. "A short review: Oral Submucous Fibrosis (OSMF)." International Journal of Pharmaceutical Research and Applications 10, no. 2 (2025): 82–84. https://doi.org/10.35629/4494-10028284.
Pełny tekst źródłaNayak, Meghanand T., Anjali Singh, Rajiv S. Desai, and S. S. Vanaki. "Immunohistochemical Analysis of Vimentin in Oral Submucous Fibrosis." Journal of Cancer Epidemiology 2013 (2013): 1–6. http://dx.doi.org/10.1155/2013/549041.
Pełny tekst źródłaAcharya, Siddharth, Sourab Kumar, Abhishek Jadhav, Priyadharshini, Faraz S., and Prince S. "Oral Submucous Fibrosis: A Case Report." International Journal of Current Research and Review 13, no. 05 (2021): 152–54. http://dx.doi.org/10.31782/ijcrr.2021.sp285.
Pełny tekst źródłaBhattacharjee, Tathagata, Supratim Ghosh, Dipto De, Pratik Sarkar, and Jay Gopal Ray. "Comparative analysis of blood vessel morphometry in advanced oral submucous fibrosis and malignancy associated with oral submucous fibrosis." Journal of Oral and Maxillofacial Pathology 29, no. 1 (2025): 12–17. https://doi.org/10.4103/jomfp.jomfp_89_24.
Pełny tekst źródłaLi, J., M. Yao, X. Zhu, et al. "YAP-Induced Endothelial-Mesenchymal Transition in Oral Submucous Fibrosis." Journal of Dental Research 98, no. 8 (2019): 920–29. http://dx.doi.org/10.1177/0022034519851804.
Pełny tekst źródłaXu, Chunjiao, Jing Zhao, Wings T. Y. Loo, et al. "Correlation of epigenetic change and identification of risk factors for oral submucous fibrosis." International Journal of Biological Markers 27, no. 4 (2012): 314–21. http://dx.doi.org/10.5301/jbm.2012.9937.
Pełny tekst źródłaQin, Xiaofeng, Yujie Ning, Liming Zhou, and Youming Zhu. "Oral Submucous Fibrosis: Etiological Mechanism, Malignant Transformation, Therapeutic Approaches and Targets." International Journal of Molecular Sciences 24, no. 5 (2023): 4992. http://dx.doi.org/10.3390/ijms24054992.
Pełny tekst źródłaBag, Swarnendu, Debabrata Dutta, Amrita Chaudhary та ін. "Identification of α-enolase as a prognostic and diagnostic precancer biomarker in oral submucous fibrosis". Journal of Clinical Pathology 71, № 3 (2017): 228–38. http://dx.doi.org/10.1136/jclinpath-2017-204430.
Pełny tekst źródłaLin, Ching-Yeh, Pei-Ling Hsieh, Yi-Wen Liao, Chih-Yu Peng, Cheng-Chia Yu, and Ming-Yi Lu. "Arctigenin Reduces Myofibroblast Activities in Oral Submucous Fibrosis by LINC00974 Inhibition." International Journal of Molecular Sciences 20, no. 6 (2019): 1328. http://dx.doi.org/10.3390/ijms20061328.
Pełny tekst źródłaLiu, Ziyi, Wenwu Hu, Zhongyan Shan, Sixuan Liu, Zhigang Yao, and Hongzhi Quan. "Evaluation of stromal myofibroblasts in oral submucous fibrosis and its malignant transformation: An immunohistochemical study." Journal of Cancer Research and Therapeutics 20, no. 2 (2024): 706–11. http://dx.doi.org/10.4103/jcrt.jcrt_498_23.
Pełny tekst źródłaShen, Yen-Wen, Yin-Hwa Shih, Lih-Jyh Fuh, and Tzong-Ming Shieh. "Oral Submucous Fibrosis: A Review on Biomarkers, Pathogenic Mechanisms, and Treatments." International Journal of Molecular Sciences 21, no. 19 (2020): 7231. http://dx.doi.org/10.3390/ijms21197231.
Pełny tekst źródłaKhatri, Musarrat J., Rajiv S. Desai, G. S. Mamatha, Meena Kulkarni, and Jay Khatri. "Immunohistochemical Expression of Mast Cells Using c-Kit in Various Grades of Oral Submucous Fibrosis." ISRN Pathology 2013 (August 29, 2013): 1–5. http://dx.doi.org/10.1155/2013/543976.
Pełny tekst źródłaPandey, Ashish. "Novel Therapeutic Approaches for Oral Submucous Fibrosis." New Medical Innovations and Research 6, no. 2 (2025): 01–03. https://doi.org/10.31579/2767-7370/143.
Pełny tekst źródłaLakshmi, Unnikrishnan, and Kumar Siddharth. "A Study of the Efficacy of Oral Colchicine in the Treatment of Oral Submucous Fibrosis." International Journal of Current Pharmaceutical Review and Research 15, no. 09 (2023): 104–9. https://doi.org/10.5281/zenodo.11649698.
Pełny tekst źródłaZheng, Lian, Zhen-Jie Guan, Wen-Ting Pan, Tian-Feng Du, Yu-Jia Zhai, and Jia Guo. "Tanshinone Suppresses Arecoline-Induced Epithelial‐Mesenchymal Transition in Oral Submucous Fibrosis by Epigenetically Reactivating the p53 Pathway." Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 26, no. 3 (2018): 483–94. http://dx.doi.org/10.3727/096504017x14941825760362.
Pełny tekst źródłaTan, Yisi, Yuting Huang, Linkai Guo, et al. "HLA-DQB1 Allele Polymorphism Associated with Oral Submucous Fibrosis in Hunan, China." Journal of Immunology Research 2024 (May 18, 2024): 1–7. http://dx.doi.org/10.1155/2024/8757860.
Pełny tekst źródłaJaganathan, Ranjit Kumar, Subramani Uma Maheswari, Devapriya Appukuttan, Dhayanand John Victor, P. S. G. Prakash, and Jasmine Crena. "Ultrasonographic Evaluation of Masseter Muscle in Patients with Oral Submucous Fibrosis." Journal of Interdisciplinary Dentistry 14, no. 3 (2024): 200–206. http://dx.doi.org/10.4103/jid.jid_58_24.
Pełny tekst źródłaMathew, D. G., and K. Ranganathan. "P1.109. Assessment of fibroblast subpopulations in oral submucous fibrosis (OSF) a precancerous condition." Oral Oncology Supplement 3, no. 1 (2009): 158. http://dx.doi.org/10.1016/j.oos.2009.06.395.
Pełny tekst źródłaBansal, Shivani P., Treville Pereira, Rajiv S. Desai, Abinashi Jena та Vini Mehta. "Expression of transforming growth factor-β in oral submucous fibrosis: A systematic review". Journal of Oral and Maxillofacial Pathology 27, № 2 (2023): 348–58. http://dx.doi.org/10.4103/jomfp.jomfp_536_22.
Pełny tekst źródłaSachdev, Prageet K., Jeanne Freeland-Graves, S. Natasha Beretvas, and Namrata Sanjeevi. "Zinc, Copper, and Iron in Oral Submucous Fibrosis: A Meta-Analysis." International Journal of Dentistry 2018 (June 26, 2018): 1–14. http://dx.doi.org/10.1155/2018/3472087.
Pełny tekst źródłaChou, Ming-Yung, Pei-Ling Hsieh, Shih-Chi Chao, Yi-Wen Liao, Cheng-Chia Yu, and Chang-Yi Tsai. "MiR-424/TGIF2-Mediated Pro-Fibrogenic Responses in Oral Submucous Fibrosis." International Journal of Molecular Sciences 24, no. 6 (2023): 5811. http://dx.doi.org/10.3390/ijms24065811.
Pełny tekst źródłaGupta, M., A. Pachauri, SK Singh, R. Ahuja, P. Singh, and SSS Mishra. "Recent Advancements in Oral Submucous Fibrosis Management: an Overview." Bangladesh Journal of Dental Research & Education 4, no. 2 (2014): 88–90. http://dx.doi.org/10.3329/bjdre.v4i2.20256.
Pełny tekst źródłaMeshram, Mrunal. "Effect Of Local Application Of Aloe-Vera Gel In The Management Of Oral Submucous Fibrosis." DMIMS Journal of Dental Research 5, no. 4 (2021): 164–67. http://dx.doi.org/10.54054/jodr.2021545.
Pełny tekst źródłaKazmi, Anum, Zia Abbas, Zohra Saleem, Safdar Haider, Waqas Ahmed Farooqui, and Shaheen Ahmed. "Relation of salivary MMP-8 with oral submucous fibrosis and oral squamous cell carcinoma: a cross sectional analytical study." BMJ Open 12, no. 12 (2022): e060738. http://dx.doi.org/10.1136/bmjopen-2021-060738.
Pełny tekst źródłaHan, Bin, Yanhui Zhang, Yuxia Xiao, Bohong Shi, Hong Wu, and Desheng Liu. "Adipose-Derived Stem Cell-Derived Extracellular Vesicles Inhibit the Fibrosis of Fibrotic Buccal Mucosal Fibroblasts via the MicroRNA-375/FOXF1 Axis." Stem Cells International 2021 (June 22, 2021): 1–15. http://dx.doi.org/10.1155/2021/9964159.
Pełny tekst źródłaPalliyal, S. "Assessment of Betel Quid Habits and Risk of Precancerous Oral Lesions Among Paniya Tribes of Wayanad, India - A Cross-Sectional Study." Journal of Global Oncology 4, Supplement 2 (2018): 12s. http://dx.doi.org/10.1200/jgo.18.16700.
Pełny tekst źródłaAlmuzaien, Mariam, Al Rayyan Mustafa, Dania Awais, et al. "Awareness of Oral Submucous Fibrosis among the Quid-Chewing South-Asian Expatriates in the United Arab Emirates." Journal of Pharmacy and Bioallied Sciences 16, Suppl 2 (2024): S1461—S1464. http://dx.doi.org/10.4103/jpbs.jpbs_966_23.
Pełny tekst źródłaShetty, Subraj, Treville Pereira, Sandhya Tamgadge, Sandeep Kale, Pooja Kamat, and Sourab Kumar. "ENDOGLIN (CD105): A marker of tumour vasculature for assessment of malignant potential of oral submucous fibrosis." Journal of Oral and Maxillofacial Pathology 28, no. 4 (2024): 589–95. https://doi.org/10.4103/jomfp.jomfp_67_24.
Pełny tekst źródłaLee, Yu-Hsien, Yi-Wen Liao, Ming-Yi Lu, Pei-Ling Hsieh, and Cheng-Chia Yu. "LINC00084/miR-204/ZEB1 Axis Mediates Myofibroblastic Differentiation Activity in Fibrotic Buccal Mucosa Fibroblasts: Therapeutic Target for Oral Submucous Fibrosis." Journal of Personalized Medicine 11, no. 8 (2021): 707. http://dx.doi.org/10.3390/jpm11080707.
Pełny tekst źródłaHaider, Rehan. "Anabolic Steroids." New Medical Innovations and Research 6, no. 2 (2025): 01–03. https://doi.org/10.31579/2767-7370/141.
Pełny tekst źródłaHolla, Vidya A., L. K. Chatra, Prashanth Shenai, Devika Shetty, and Ashwini Baliga. "A Study to Analyze Different Patterns of Quid Usage among Subjects with Oral Submucous Fibrosis in Mangalore Population." Advances in Medicine 2016 (2016): 1–5. http://dx.doi.org/10.1155/2016/6124059.
Pełny tekst źródłaChiu, Hui-Fang, Chang-Shyue Yang, Hsien-I. Chi, et al. "Cyclooxygenase-2 expression in oral precancerous and cancerous conditions and its inhibition by caffeic acid phenyl ester-enriched propolis in human oral epidermal carcinoma KB cells." Archives of Biological Sciences 69, no. 1 (2017): 83–91. http://dx.doi.org/10.2298/abs160324081c.
Pełny tekst źródłaElangovan, Elampavai, та Elanangai E. "Correlation of CD1a Positive Langerhans Cells and Transforming Growth Factor β in Oral Submucuous Fibrosis - An Immunohistochemical Study". International Journal of Clinical Oral and Maxillofacial Surgery 11, № 1 (2025): 40–52. https://doi.org/10.11648/j.ijcoms.20251101.15.
Pełny tekst źródłaLee, Yu-Hsien, Pei-Ling Hsieh, Shih-Chi Chao, Yi-Wen Liao, Chia-Ming Liu та Cheng-Chia Yu. "α-Mangostin Inhibits the Activation of Myofibroblasts via Downregulation of Linc-ROR-Mediated TGFB1/Smad Signaling". Nutrients 15, № 6 (2023): 1321. http://dx.doi.org/10.3390/nu15061321.
Pełny tekst źródłaDr., Tayyab Tufail Dr. Mudasir Shah Dr. Haseeb Uddin. "A COMPREHENSIVE STUDY ON CORRELATION OF SMOKING AND SURVIVIN IN ORAL SUBMUCOUS CARCINOMA." INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES 06, no. 01 (2019): 1170–73. https://doi.org/10.5281/zenodo.2542090.
Pełny tekst źródłaSarkar, Rupam. "Journey from Oral Sub mucous Fibrosis (Osmf) to Functional Disease-Free Mouth Opening." Journal of Health Physiotherapy and Orthopaedics 1, no. 1 (2024): 22–27. https://doi.org/10.55522/jhpo.v1i1.0008.
Pełny tekst źródłaMd. Asdullah, Nasir A. Salati, Masood H. Khan, R. K. Tiwari, Pradhuman Verma, and Anshul Aggarwal. "Comparative study of rebamipide & betamethasone in managing stomatopyrosis in oral submucous fibrosis (OSMF) patients." Journal of Oral Medicine, Oral Surgery, Oral Pathology and Oral Radiology 7, no. 3 (2021): 157–60. http://dx.doi.org/10.18231/j.jooo.2021.049.
Pełny tekst źródłaMurthy, Vignesh, Petros Mylonas, Barbara Carey, et al. "Malignant Transformation Rate of Oral Submucous Fibrosis: A Systematic Review and Meta-Analysis." Journal of Clinical Medicine 11, no. 7 (2022): 1793. http://dx.doi.org/10.3390/jcm11071793.
Pełny tekst źródłaIndra G, Maragathavalli G, and Deepika Rajendran. "Complete Blood Count as a Diagnostic Marker in Oral Lichen Planus." International Journal of Research in Pharmaceutical Sciences 11, SPL3 (2020): 1766–71. http://dx.doi.org/10.26452/ijrps.v11ispl3.3510.
Pełny tekst źródłaMadusanka, G. T., N. S. Piyarathne, D. A. Satharasinghe, and R. D. Jayasinghe. "Phenotypic species identification and ALS3 gene analysis in Oral <em>Candida albicans</em> isolates in patients with Oral Submucous Fibrosis – A Sri Lankan study." Ceylon Journal of Science 54, no. 3 (2025): 791–97. https://doi.org/10.4038/cjs.v54i3.8702.
Pełny tekst źródłaAslam, Sidra, and Sarah Ghafoor. "Insulin-like growth factor-I signaling plays a pivotal role in the development of oral premalignant lesions in patients with diabetes mellitus." BioMedica 38, no. 3 (2022): 129–33. http://dx.doi.org/10.51441/biomedica/5-759.
Pełny tekst źródłaSevlani, Sonia T., Sheetal Gondkar, and Ravindranath Saudagar. "A REVIEW Oral Sub Mucous Fibrosis: A Review." Journal of Drug Delivery and Therapeutics 9, no. 3 (2019): 712–15. http://dx.doi.org/10.22270/jddt.v9i3.2898.
Pełny tekst źródłaAthukorala, Isuru, R. M. S. H. B. Medawela, Malika Gunawardana, and R. D. Jayasinghe. "GIS to Explore the Geographical Mysteries of Oral Cancer: Geospatial Distribution of Patients Diagnosed with Oral Potentially Malignant Disorders at the University Dental Hospital Peradeniya." Asian Pacific Journal of Cancer Care 7, no. 1 (2022): 29–35. http://dx.doi.org/10.31557/apjcc.2022.7.1.29-35.
Pełny tekst źródłaMisbahul, Haque. "Pre- and Post-Treatment Comparison of Intralesional Dexamethasone and Hyaluronidase for Managing Oral Submucous Fibrosis (OSMF)." International Journal of Pharmaceutical and Clinical Research 16, no. 11 (2024): 2002–6. https://doi.org/10.5281/zenodo.14637495.
Pełny tekst źródła